189 Posts

Forefront Capital has floated its initiative, Forefront Income Trust, in the market. The innovative investment fund caters for the non-accredited investors. For the longest time, Brad Reifler focused on accredited investors. Accredited investors are those that make over $200,000 in a year or have a net worth of more than $1 million. The Securities and Exchange Commission (SEC) also reflects this statistics. Brad Reifler pointed out that he was now shifting the focus to non-accredited investors with a specific plan developed for them.

Originally, the accredited investor standards were developed to protect shareholders from risky investments. Nevertheless, knowledge and oversight in the capital market has increased within the last 30 years. SEC has recommended important updates to the meaning of accredited investor. Additionally, an Investor Advisory Committee was created in 2010. The committee was mandated by the Dodd- Frank Act with the task of reviewing the definition after every four years. The recommendation of the committee was to do away with the present net worth and income tests developed 32 years ago. They were to change the measures in line with financial sophistication.

It’s pretty clear from CrunchBase that Reifler created Forefront Income Trust after careful analysis and due diligence. The trust offers non-credited investors an opportunity to invest a minimum of $2,500 that can be withdrawn or added every quarter. The Forefront Income Trust products allow room for potential growth and high risks since they are not correlated to the stock market. According to Reifler, they offer interesting distinctive programs that can provide clients with liquidity and a return of 8%.

Brad Reifler made his first investment in a 529-college plan many years back as referenced on Wikipedia. This investment was available to all regardless of their income or worth. When his girls were to join college, the fund was 40% lower making him incur losses. His attention to the middle class was drawn more after his father in-law gave him his savings to invest. However, his father in law’s investment strategies could not materialize because he was not a credited investor. Reifler realized how limited investment opportunities were available to many people.

Brad Reifler is the CEO of Forefront Capital Management and Forefront Advisory. He is a highly experienced and qualified individual with having over 30 years experience. Reifler established his first company, Reifler Trading Corporation, in 1982 after graduating with a degree in economics and political science from Bowdoin College. Refco bought the Company in 2000.

Later, Reifler established Pali Capital where he achieved even greater success. Serving as the chairman and CEO, Reifler led the company to profits surpassing over $200 million. He also established offices in the United States, Australia and United Kingdom. Reifler would like to be recognized as an individual that people can trust in offering investment alternatives. His goal is to demystify the investment complexity in a bid to elicit the public to invest and secure their futures through their savings.

In the internet world of sales, there is one company that leads the way in sales. That one business is Amazon. The internet has a large amount of stores that carry everything that you could possibly want or need. The trick to being successful in the market is to offer something that others do not offer. If you want to sell the same items or similar items, the brand needs to be backed by someone who claims that the item from them is the best. For Fabletics, they knew that they had to stand out against all the others if they were going to make headway against Amazon.

 

Fabletics approached Kate Hudson to be the spokesperson for the business. The belief was that if Kate has been seen promoting these items, more people will shop for the brand. The problem with most businesses is that the person speaking on behalf of the business is not someone that usually is found outside of the commercials to wear the items that they are selling. Kate Hudson however is an avid athlete and therefore spends quite a bit of time herself working out. When people take her photograph entering into a gym, the brand of workout gear that she is seen sporting is Fabletics.

 

Social media is working in overdrive to help promote merchandise for a much smaller cost than what the business would spend on opening a physical store or by purchasing air time to play commercials. Fabletics uses the social media to bring in sales for their workout line however they also have air time that invites others to try the line of products.

 

In the market where Amazon is the leading contender for all sales related shopping experiences, it is hard to compete with such a popular internet business however there are some businesses that are pushing through the difficulties and bringing in more sales. Fabletics knows what people want and works to bring in more consumers. The membership business is delivering workout gear to the homes of the people that want to look stylish when going to the gym. The gym that people normally went to in a plain, unstylish type of gear is now being filled with Fabletics members who want to look good when working out.

 

The shoppers who are purchasing the gear by Fabletics is in love with the idea that the workout gear can be worn outside of the gym. You can wear the athletic wear to more than just the gym. The workout gear can be worn to the grocery store, to dropping off the kids at school, to the mall and even to a dinner. The gear is stylish allowing the shoppers to purchase gear that they do not have to change right out of when you are done working out. Kate Hudson is someone that is seen wearing the clothes outside of the gym and this helps to increase the sales. Most consumers will appreciate the fact that the athletic wear is comfortable and can be worn for a number of reasons and not just to the gym.

As most people are aware, healthcare costs in America are skyrocketing. This has resulted in $933 billion more being spent on people’s healthcare in 2013 versus back in 1996. The care today is much better than even back then but it’s also a lot more intense and costly. A lot of it is also being driven by there being a lot more people in the United States and more people living much longer than people tended to years ago.

Two of the areas that people are spending much more money is to treat diabetes as well getting treatment for neck and low back pain. The increase in spending on diabetes is mainly attributable to expensive pharmaceuticals to manage it. While more people aren’t experiencing back and neck pain more people are doing something about it by getting medical treatment of their condition. This has resulted in a lot more healthcare spending.

Annual spending on healthcare now stands at $697 billion. There had been efforts to reduce this but to little avail so far. One person in the industry said that the amount spent on healthcare each day has gone through the roof despite the best efforts of those concentrating on reducing the costs. One justification for this is that even though drug prices are higher than ever they keep people out of the hospital, which isn’t really the case.

Eric Lefkofsky is one person trying to reduce the cost of healthcare in regards to cancer treatment. The company he co-founded, Tempus, Inc., helps doctors personalize cancer care. His company collected a huge amount of molecular and clinical data that it developed into a database for use by cancer doctors. As it is DNA-based it cuts out a lot of the guesswork on what treatment will work best for each patient, reducing the costs and achieving better patient outcomes.

As a longtime entrepreneur, Eric Lefkofsky is well acquainted with big ideas like Tempus and how to run the company. He has also founded or co-founded other big companies in the past such as Groupon. He sees problems that technology can address and then effectively builds companies around the solutions.

With all of the research that is being done today, the Cancer Treatment Centers of
America are at the forefront. They are affiliated with the NantHealth Company. This is
a company which is a software developer. They also are the designers of the Clinical
Pathways, which are used . These Clinical Pathways are designed by this company
with the patient in mind. What these Clinical Pathways do is to Integrate the latest
Cancer research available with treatment regimens. Then they align the complimentary
therapies available. They customize the treatment regimen to the patient and this platform

targets the specific disease state. The regimens are made available to the physicians by
a tap on their computer screen. This makes it safe for the patient and efficient.
They have also aligned themselves with a company called AllScripts. This
company is a leader in the information technology. In this capacity the help to advance
the Clinical, financial and also they obtain the operational results.
They connect people with Cancer with their Open and connected Community of Health.
By this technology being available to physicians , it enables them to work with their
patients and make better decisions for the treatment.
Cancer Treatment of America is a company which has five hospitals in
the United States. They work with their patients to decide what the best course of
treatment would be for them. They introduce all of the therapies which are available
to them and they assist the patient by explaining what may be needed, They offer
the following treatments. Surgery, radiation, immunotherapy, and chemotherapy.

The treatments are evidence based informed therapies designed
to help patients physically and emotionally by enhancing the quality of life.
Cancer Treatment Centers of America focuses on adult cancer patients, and they serve
cancer patients from every part of the world.

Mikhail Blagoskylonny is one of the influential oncology experts who is situated in New York City. His recognition is because of the exceptional research in cancer and aging. Most important thing is the findings that he has been able to come up with which has massively assisted in developing the oncology segment. At Rosewell Park Cancer Institute is where he always carries out his daily activity and has always worked as a professor from 2009. Furthermore, as a scientist, he has also has been included in writing and publishing cherished material that mainly emphases on cancer and aging. He is well known for motivating medical experts all over the world to use Rapamcyin in extending the lives of their patients. Mikhail also expanded the admiration in the medical rsearch sector because of the outstanding understanding of oncology.

Rapamycin has exceptional features that enable it to perform well in treating cancer and also the best drug this is according to scientific research. Furthermore, it also treats other dangerous diseases such as lymphangioleiomyomatosis (LAM), tuberous sclerosis complex (TSC) hemolytic-uremic syndrome and facial angiofibromas. The organization enabled the drug to be supplied all over the world and patients can get them easily in pharmacies. In the year 1972 is when Rapamycin was started to be used since it was revealed from a strain of bacteria that was located on Eastern Island. At first the drug was used as an anti-fungal agent but later on, the scientist became aware of the features of Rapamcyian as an immunosuppressive and antiproliferative.Due to the establishment of cancer therapies he has been known to make major innovation hence he is well recognized all over the world. Also, he led the unparalleled studies on specific cancer and anti-aging treatment. He is also certain that cancer is connected with aging because it typically affects people who have reached a particular age.

Most of the young people always see him as their role model due to the achievement in the oncology segment. Blagosklonny’s journey career has been thriving due to the amazing academic qualification. His education background is outstanding. He went to First Pavlov State Medical University of St. Peterburg and attained his Ph.D. Also, he got his master’s degree in internal medicine from the establishment as well. New York Medical College is where he started working as researcher in the year 2002, then he, later on, moved to Ordway Research Institute due to the knowledge that he attained hence he served at the organization as the senior researcher and then in the year 2009 he decides to live the organization and join Roswell Park Cancer Institute.His main daily activity at the organization was too always help in the innovation of differently targeted cancer cure. Apart from that he also studied on the specialization of aging mechanism and anti-aging drug growth. A modern research project that he is currently doing is being attentive on learning how aging and cancer are affected by the TOR signal. Lastly, also is part of the editor in the research fields that include cancer biology and therapy.

Oncotarget is the name of a medical journal that comes out on a weekly basis. The journal, as its name suggests, discusses many topics that pertain to the world of oncology. The publication was launched back in 2010. Impact Journals publishes it. Andrei V. Gudkov and Mikhail Blagosklonny both serve as Oncotarget’s editors-in-chief. IntegraGen is a company that focuses on a wide ranges of specialties. It concentrates on turning biological sample data into invaluable genomic details that can aid the field of oncology. The firm has just recently revealed the existence of an Oncotarget publication that delves into the relationship between metastatic colorectal cancer and miR-31-3p expression amounts.Oncotarget is a journal that takes a multidisciplinary approach. It’s a free access publication that has a large and devoted following.

People can read Oncotarget publications via the Internet. It can make a helpful resource for people who want to learn about all matters that relate to advancements and innovations in the oncology realm. It can also make a wonderful resource for people who want to learn more about topics such as chromosomes, cell death, autophagy, microbiology, immunology, pathology, aging and more. People who have interest in cancer and in hereditary factors frequently gravitate to the diverse publications that are available through Oncotarget each and every week.Gudkov is an editor-in-chief who works for Buffalo, New York’s Roswell Park Cancer Institute. Oncotarget’s other editor-in-chief works for the same educational institution. This is Blagosklonny. Gudkov and Blagosklonny have the assistance of a hard-working editorial board. The talented people who make up this board are Brian J. Duker, Ronald A. DePinho, Frederick Alt, Peter K. Vogt, Bert Vogelstein, Alexander Varshavsky, Gregg L. Semenza, Arthur B. Pardee, Carlo M. Croce and Arnold Levine. These capable professionals all represent a vast range of entities.

They work for institutions of higher learning such as Harvard University, Ohio State University and the Scripps Research Institute. These institutions are based in many locations all around the United States. Oncotarget is a renowned publication that always aims to keep up with changes in the oncology universe. It’s also one that constantly strives to stay ahead of the rest of the pack in the online world. Oncotarget has a great and reliable presence in social media. The publication has active presences on many widely known and beloved social networking websites. Examples of these social media platforms are Facebook, LinkedIn, Google Plus, YouTube and Twitter. People who wish to get in contact with the team members who work for Oncotarget can easily do so through channels such as Facebook and Twitter. The Oncotarget staff makes a point to get back to people quickly. They make a point to answer oncology questions in considerable detail as well. Oncotarget has approaching 1,800 followers on Twitter. The publication posts regular short messages that keep these people in the loop. These messages talk about publication frequency. They talk about changes in editorial standards and guidelines. They talk about all matters that involve how the journal works.

OSI Group has become one of the world’s foremost food processing companies as they provide high-quality products while partnering with top retail brands. They have steadily grown into world-class enterprise under the ownership and leadership of Sheldon Lavin and are currently operating in 17 different countries. Their capabilities are equaled by few as their range of services continues to expand. They are able to develop a concept with the expertise of their culinary staff and are also able to bring it into production with their tremendous resources.

An acquisition that makes sense has been a hallmark of OSI Group and they are adept at buying companies that complement their own resources. One recent example is purchase of Baho Food which is a Dutch manufacturer of convenience foods, deli meats, and snacks. This adds to their already substantial presence in Europe and helps Baho as well with the increased strength of the combined companies.

One reason that OSI Group has realized an extraordinary level of success is their appreciation of and reliance on their employees. They are convinced that their accomplishments are as a result of dedicated workers who bring a spirit of entrepreneurialism and innovation to their jobs every day. They strive to cultivate an atmosphere that challenges workers encourages them to grow and develop their skills to the height of their potential.

The inclusive workforce of OSI Group is well known in the food processing industry and they are a corporate model for others hoping to realize greater diversity. They are particularly interested in passionate individuals who display enthusiasm for their careers and bring an innovative mindset with them. The company is convinced that everyone has the potential to make a difference and their business is the stronger for it.

The infrastructure of OSI Group is extensive and they offer customized solutions made to customer specifications. They are experts in forging strategic partnerships which benefit both companies and allow for the greater prosperity of both. Their design facilities are state-of-the-art and help bring ideas to life. The teamwork ethic that OSI adheres to is another aspect of their success that separates them from run-of-the-mill entities with global reach.

To know more visit @: www.monster.com/jobs/c-osi-group.aspx

Who is IDLife and why are they so important to the health of people today? We’ll let’s find out the answer to this question. IDLife is a health and wellness company that started in 2014 by its CEO and founder, Logan Stout. Mr. Stout had a vision. Logan Stout wanted people to understand the importance of being healthy and living a sound life.

The company believes that no two people are alike. Since they are not, they need individualized plans that are suited for specifically for them. The IDLife process is designed to ensure that people can get the type of nutrition that they need to live a well-balanced life. The company offers the high-quality products that are packed with ingredients that people need to survive and thrive.

IDNutrition is a vitamin program offered by organization. Consumers can get a customized vitamin regimen that will help them to maximize their health benefits through this program. The company also creates shakes which are flavorful and packed with excellent nutrients. They even have a flavored water mix called IDLife Hydrate which is designed to help people to stay refreshed and replenished.

Former NFL quarterback Troy Aikman is a spokes person for this organization. He has been on board with this organization for years. One interesting thing about IDLife is that they have nutritional products for kids. These products are marketed under Kids Line. Consumers can even get some high-quality skin care with IDLife Skin Care Products.

The IDLife brand and products are among the best in the field of health and nutrition. Many people who use the company’s programs and products know that they are among the best in this field. The IDLife staff and users know that this company provides the best services for people to use. They truly work hard to ensure that users are getting the best products possible.

To know more visit @: www.youtube.com/watch?v=jPqdr4WK-ig

The latest studies show that frequent drinking of coffee may have some positive benefits to your body. Drinking coffee is connected to reduce heart disease, aging and stroke this is according to the latest done recently and published studies by Annals of Internal Medicine. Drinking of coffee limitation and benefits has been in the limelight for many years, and numerous studies were done to prove if the benefits like longer life are possible. Studies done to over one hundred and eighty-five American showed that coffee is associated with positive benefits to the body that includes lower risks of stroke, cancer, diabetes, kidney disease, and heart diseases.

The studies were done on different races of Americas including the whites, Latinos, Japanese Americana and African Americans making the results more diverse and accurate. According to Dr. Veronica W. Setiawan, an associate preventive medicine professor at Keck School of Medicine those who drink coffee at least three or more cups per day have 18 % chance of decreasing their death and living longer lives than those who haven’t touched coffee in 16 years. It was concluded after a group of coffee drinkers was formed to report their coffee drinking habits and drinking of coffee has an association with prolonged life. Another research conducted by a European company and over ten organizations said the same findings, and prolonged coffee drinking extends their lifespan.

Organo Gold is a company that deals with global networking marketing and has a unique mission of changing the lives of people. Organo Gold believes that they can reach thousands of people globally to help them achieve their equal level of well being and freedom. According to Organo Gold Company, all this is possible through their business opportunity and premium products which includes nutraceuticals, beverages, and personal care products. The company has a vast connection in over 50 countries, and their primary mission is bringing people of the world the most treasured gifts for their health and personality.

For more information follow Organo Gold on Twitter.

In a world where many are quick to make assumptions, billionaires are often seen as self-centered. Some frown at the fact that billionaires use their riches to purchase excessive luxuries while many do not have the resources to afford even the most basic of needs. However, there are a few billionaires that fall nowhere near this categorization. Chief among them is hedge fund manager and investor, George Soros. The Hungarian-born American is unofficially known as one of the most charitable billionaires in the world. Proof of this is seen in the fact that he has contributed about $12 billion of his own wealth towards various charitable and political causes.

Over the course of the last three decades, George Soros has greatly been involved in the advancement of democracy in Central and Eastern Europe. He was one of the earliest individuals to get involved in the democratization of the states that formerly constituted the Soviet Union through the umbrella organization known as the Open Society Foundations. The first foundation created under the Open Society was launched in Hungary in 1984. Since then, the Open Society Foundations have grown significantly spurred on by the need for democracy and George Soros’s contributions. However, it is important to note that Soros does not just donate resources to these organizations blindly. To avoid too much dependence on him, the resources he provides make up no more than a third of these foundation’s budgets.

George Soros has also been greatly involved in American politics. While the United States is rightfully considered by many to be the champion of democracy and human rights, there are still many battles to be worn. Soros has previously strongly opposed presidential candidates that have extremely leaned to the right and has instead supported liberal candidates. In particular, he has strongly been against the presidential bids of George Bush in 2004 and Donald Trump in 2016.

Because he did not always have what he needed growing up, George Soros is quite passionate about philanthropy. He has supported millions of people from all over the world in the areas of education, health entrepreneurship and much more. Among his earliest charitable acts was providing black South African students with scholarships to attend the University of Cape Town while the country was still under strict apartheid rule. In recent years, he has also put significant resources towards advancing the plight of refugees and tackling the rising prevalence of hate crimes.

George Soros has made sure to pass on the wealth of knowledge that he holds to the general public through a number of books that he has authored. These books explore a raft of topics including securities trading, politics, economics and life in general.

 

Cancer is a disease that affects almost everyone across the world, either directly or indirectly. Aging is also another factor in life that simply touches everyone; it’s a fact of life that you will age. But Mikhail Blogosklonny wants to try and fix those two problems. Blogosklonny has been conducting research into cancer and its connection to the age of the patients who contract the deadly disease. With this research, he hopes to change the oncology game forever.

Cancer as a whole is a disease that can be painful physically, mentally, emotionally, but also financially. The treatment of cancer can drag on for months and even years and while doctors and science is closer to making the treatments more effective than they have been in the past, there is still a long ways to go to make it widely available for all to have access too. Blogsklonny wants to make sure that anyone in the world, no matter their financial situation, can have access to the same care as everyone else.

Mikhail also is trying to change how cancer is treated. When people go through cancer treatment, the chemotherapy and other methods all have their positives and negatives. One of the negatives would be the destruction of the healthy cells that would normally aid in the healing process after the fact. Mikhail Blogsklonny wants to try and find a way to treat the bad cells inside the human body, while sparing the healthy cells to try and have the healing process speed up. One way he is trying to do this is by using an anti-organ transplant drug to help with the healing process. Rapamycin is the drug that is currently being talked about as the next best drug to help with the problems of cancer and aging. The drug is originally used for helping with organ transplantation, where the person receiving a new organ would take Rapamycin to make sure his/her body did not reject the new organ. But in the case of cancer treatment, Rapamycin works by targeting the immune system to fight off the bad, cancerous cells and promotes tumor regression inside the body.

The other area of research that Mikhail Blogsklonny is doing more research on would be agism. In the recent tests he has conducted on lab mice, using Rapamycin has shown to provide more energy and life to mice battling tuberculosis. Also, Rapamycin has also been shown to have some effects on the reduction of brain lesions and preventing cognitive defects in mice. And while this may not be an end-all cure for Alzheimer disease, the research thus far has been positive. Many people want to leave an impact on the world when they eventually leave. Mikhail Blogsklonny is certainly trying to make sure his name ends up in history with the research he is doing. If he even comes up short, he will still have a lot to show for all of his work on Earth.